Fact CheckerSign in

NCT07656857Recruiting

High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT

Precision Resection of the Epileptogenic Zone Using Intraoperative Submillimeter Micro-Electrocorticography (Epi-PRECISE): A Single-Arm Trial With an External Historical Control Cohort

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Brief summary (registry, in English)

What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?

Status (registry)
Recruiting
Study type
Interventional
Enrollment
85 (estimated)
First submitted
15 Jun 2026
Start date
1 Sept 2026
Primary completion date
31 Jul 2028
Lead sponsor
Beijing Tiantan Hospital
Diseases
Epilepsy
NCT number
NCT07656857

What you commit to

  • Study type: Interventional
  • Planned participants: 85
  • From 1 Sept 2026 to the primary completion date, 31 Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of any previous neurosurgical craniotomy before epilepsy surgery.
  • Contraindication to surgery.

Other illness

  • Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation.
  • Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up.

Who the study is looking for

  • Age 3 to 60 years.
  • Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications.
  • Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery.
  • Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required.
  • Written informed consent provided by the participant or, when applicable, by a legal guardian.

Age in the registry: 3 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Tiantan Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.